PUVA is a form of repigmentation therapy where a type of medication called psoralen is given before exposure to ultraviolet light A (thus the name PUVA). It is generally used for people with more extensive Vitiligo (affecting greater than 20% of the body), and is the mainstay of treatment for Vitiligo patients. Psoralen makes the skin very sensitive to light. Combined with UVA, it stimulates the production of the pigment melanin in the skin. Basically, it serves to help the patient tan faster in a small amount of time. PUVA therapy has a 50-70% chance of returning color on the face, trunk, and upper arms and legs, whereas hands and feet respond poorly ...
Studies during Photochemotherapy of Psoriasis. This study also shows the importance of pharmacokinetics in the therapy management of poor responders to PUVA. PUVA is useful for patients with various skin disorders, including psoriasis, dermatitis, polymorphic light eruption, and mycosis fungoides. P. Dietary influences on 8-MOP plasma levels in PUVA patients with psoriasis. Bath PUVA treatment for psoriasis was first reported by Fischer and Alsins in 1976. The patient wears the suit for a fixed duration and is then exposed to UVA rays. It has been shown that higher PASI scores are associated with higher plasma levels of psoralen. Dietary influences on 8-MOP plasma levels in PUVA patients with psoriasis. MINIMAL PHOTOTOXIC DOSES OF 8-MOP PLASMA LEVELS IN PUVA PATIENTS. Its effectiveness has profoundly influenced dermatologic therapy in general, providing treatment for a number of diverse disorders besides psoriasis and vitiligo. PUVA can be combined with topical treatments and with some systemic ...
Vitiligo is a condition of the skin that causes patches of the skin to have all pigmentation removed. Vitiligo is an autoimmune condition commonly treated with two different forms of light therapy. Learn about one form of therapy, PUVA, and its effectiveness for vitiligo below.
Palmoplantar pustulosis (PPP) is a chronic recurrent skin condition characterized by the presence of pustules, erythema and hyperkeratosis on palms and soles. PPP can be a severe and disabling disease limiting the ability to walk or work. Although studies on the quality of life of patients with PPP are not available, a recent investigation showed that palmoplantar psoriasis (non pustular) has a more important impact on quality of life than plaque psoriasis. This important impact on quality of life is not surprising as palmoplantar psoriasis as well as palmoplantar pustulosis may limit the ability to work or conduct activities with hands or even impair walking. The disease is sometimes associated with psoriasis elsewhere on the body. Current treatments for PPP include topical corticosteroids, cyclosporine, PUVA therapy, methotrexate and acitretin. Response to topical corticosteroids and PUVA therapy is often disappointing presumably because the thickness of the stratum corneum on palms and soles ...
Extracorporeal photochemotherapy (ECP) is a therapeutic procedure which combines leukapheresis and PUVAtherapy (psoralen plus UVA radiation). This novel form of cell therapy consists of collection of mononuclear cells and their irradiation with UVA in the presence of a photoactivable molecule (8-methoxypsoralen), before being reinfused. ECP was developed to induce a modulation of immune response similar to that observed after in vivo phototherapy. The photophoresis procedure requires three steps including white blood cells collection, and the precise control of psoralen concentration and UVA dose. Advantages and inconvenients of the two ECP procedures available for human use are respectively discussed. Mechanisms of action of ECP are currently incompletely defined and different hypotheses are suggested. On the molecular level, DNA, cell membrane, and cytoplasm are involved in the biologic effects of EPC. The therapeutic effect of ECP is likely induced by the combination of different bi ological ...
Some devices advertised on this website may not be licensed in accordance with Canadian law. Last Revision Date: 01/16/2018 - LIT0041REV20. ...
Phototherapy with photochemotherapy (PUVA) is a well-known and well-studied modality for the treatment of psoriasis, which involves systemic or topical administration of chemicals known as psoralens and administration of ultraviolet light in increasing dosages after requisite time gap. PUVA is also used in the treatment of widespread vitiligo with moderately good results, though it is being surpassed by ultraviolet B (UVB), which is equally or slightly more efficacious with fewer side effects. PUVA induces repigmentation by varying mechanisms such as stimulation of melanogenesis, immunomodulation and activation of growth factors, though the exact mechanism is still speculative. Read More ...
Dyshidrosis, is a type of dermatitis, that is characterized by itchy blisters on the palms of the hands and bottoms of the feet. Blisters are generally one to two millimeters in size and heal over three weeks. However, they often recur. Redness is not usually present. Repeated attacks may result in fissures and skin thickening. The cause is unknown. Triggers may include allergens, physical or mental stress, frequent hand washing, or metals. Diagnosis is typically based on what it looks like and the symptoms. Allergy testing and culture may be done to rule out other problems. Other conditions that produce similar symptoms include pustular psoriasis and scabies. Avoiding triggers may be useful as may a barrier cream. Treatment is generally with steroid cream. High strength steroid creams may be required for the first week or two. Antihistamines may be used to help with the itch. If this is not effective steroid pills, tacrolimus, or psoralen plus ultraviolet A (PUVA) may be tried. About 1 in 2,000 ...
Citation: Cooke, M.S., Evans, M.D., Burd, R.M., Patel, K., Barnard, A., Lunec, J. and Hutchinson, P.E. (2001) Induction and excretion of UV-induced 8-oxo-2-deoxyguanosine and thymine dimers in vivo: implications for PUVA. Journal of Investigative Dermatology, 116, pp. 281-285 ...
BACKGROUND: Extracorporeal photochemotherapy (EPC) has recently been proposed for the treatment of adults with either acute or chronic GVHD. However, data on children given this therapy are scarce. A Phase I-II study was carried out on EPC in children experiencing GVHD after allogeneic transplantation of HPCs.. STUDY DESIGN AND METHODS: Nine patients with steroid-resistant, grade II-IV acute GVHD and 14 with chronic GVHD, all of whom had been refractory to at least one line of treatment, were enrolled in this study and analyzed. The median age was 10.3 years (range, 5.4-18.1), and the median body weight was 35 kg (range, 17-89).. RESULTS: Seven of the nine patients with acute GVHD showed a response to EPC, whereas the disease progressed in the remaining two children (both with skin, gastrointestinal, and liver GVHD), and they died of grade IV acute GVHD. Among the seven children who responded to EPC, it was possible to completely discontinue immunosuppressive treatment in three. In the 14 ...
Large plaque parapsoriasis (also known as "parapsoriasis en plaques") are skin lesions that may be included in the modern scheme of cutaneous conditions described as parapsoriasis. These lesions, called plaques, may be irregularly round-shaped to oval and are 10 cm (4 in) or larger in diameter. They can be very thin plaques that are asymptomatic or mildly pruritic. Large-plaque parapsoriasis is a common associate of retiform parapsoriasis, can be accompanied by poikiloderma vasculare atrophicans, and can in rare occasions be a precursor to cutaneous T-cell lymphoma. Parapsoriasis treatment consists primarily of light therapy (more specifically PUVA therapy or UVB therapy) possibly in combination with topical steroids. Large plaque parapsoriasis is usually a chronic condition that needs long-term treatment. List of cutaneous conditions Mycosis fungoides Kikuchi, A.; Naka, W.; Harada, T.; Sakuraoka, K.; Harada, R.; Nishikawa, T. (1993). "Parapsoriasis en plaques: its potential for progression to ...
1 Promotional literature can be a confusing mix of different numbers when trying to compare the effectiveness of psoriasis treatments. Some studies use the PASI (Psoriasis Area and Severity Index ) system, while others use a physician assessment of clearance (sPGA) or disease resolution. In the studies that use both metrics, psoriasis clearance is considered to be at least a 75% decrease in PASI score. Since few practitioners use the PASI analysis clinically, clearance rate (sPGA) seems like a more useful comparison tool.. 2 Comparison of clinical efficacy and cost effectiveness of psoralen plus ultraviolet A light phototherapy (PUVA) versus PUVA plus sunlight (PUVASOL) therapy in chronic plaque psoriasis in Indian patients Journal of the American Academy of Dermatology, Volume 60, Issue 3, Pages AB153-AB153. 3 Palmer, et al. Photoadaptation during Narrowband Ultraviolet-B Therapy Is Independent of Skin Type: A Study of 352 Patients Journal of Investigative Dermatology (2006) 126, ...
Have you recently observed red itchy rashes all over your babys soft smooth skin? For treating eczema in children over the counter medications in conjunction with home remedies may be prescribed. Psoriasis On Your Eyelids Over Strain Stress Diagram hot spots are also known as acute moist dermatitis and they re usually found in dogs that have longer coats or in those that have a more dense undercoat though this isnt always the case. And one way is to buy milk formula without allergy.. In addition to joints this form of psoriatic arthritis can affect an adults skin and nails. PUVA therapy is usually given initially 2 to 3 times a week then less frequently as the skin improves. Cure eczema fast with these natural interventions that are proven safe and effective. Fortunately there are ways you can manage the cost of your psoriasis treatments and lower your out-of-pocket expenses. The first phase of dog eczema begins with noticeable hair loss.. You have ringworm on your scalp or beard. Other such ...
Vitiligo (leucoderma) Treatment at AK Clinics Ludhiana & New Delhi includes evaluation, its cure and white skin to normal skin color. Facilities - PUVA Therapy & surgical methods.
Extracorporeal photopheresis (ECP) is a leukapheresis-based therapeutic procedure that has been approved by the US Food and Drug Administration (FDA) for the treatment of advanced cutaneous T-cell lymphoma (CTCL) since 1988. ECP, also known as extracorporeal photochemotherapy and extracorporeal photoimmunotherapy, is performed at over 200 cen...
STELARA is a new, fully human monoclonal antibody with a novel mechanism of action that targets the p40 subunit of the cytokines interleukin-12 (IL-12) and interleukin-23 (IL-23). IL-12 and IL-23 are naturally occurring proteins that are important in regulating immune responses and are thought to be associated with some immune-mediated inflammatory disorders, including plaque psoriasis.. STELARA is licensed for the treatment of moderate to severe plaque psoriasis in adults who failed to respond to, or have a contraindication to, or are intolerant to other systemic therapies including ciclosporin, methotrexate and PUVA (psoralen plus ultraviolet A light).(5). Centocor Ortho Biotech Inc. developed STELARA and has exclusive marketing rights to the product in the United States. Janssen-Cilag has exclusive marketing rights in all countries outside of the United States. Centocor, Inc. and Janssen-Cilag are members of the Johnson & Johnson family of companies.. References:. 1. National Institute for ...
Klemke, C D; Booken, N; Weiss, C; Nicolay, J P; Goerdt, S; Felcht, M; Géraud, C; Kempf, W; Assaf, C; Ortonne, N; Battistella, M; Bagot, M; Knobler, R; Quaglino, P; Arheiliger, B; Santucci, M; Jansen, P; Vermeer, M H; Willemze, R (2015). Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases. British Journal of Dermatology, 173(1):93-105.. Whittaker, S; Ortiz, P; Dummer, R; Ranki, A; Hasan, B; Meulemans, B; Gellrich, S; Knobler, R; Stadler, R; Karrasch, M (2012). Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056). British Journal of Dermatology, 167(3):678-687.. Olsen, E A; Whittaker, S ...
We hypothesized that activated platelets induce monocyte-to-dendritic cell (DC) differentiation. The aims of this study were to: (1) determine the role that platelets play, if any, in the signaling of monocyte to DC differentiation; (2) determine the mechanism of action by which platelets induce monocyte-to-DC differentiation. (3) Use this knowledge to advance cancer immunotherapy. To achieve these ends: (1) parallel-plate flow chambers were designed to deliver monocytes a controlled level of platelet exposure, with phenotype and genotype assessed following overnight incubation; (2) blocking antibodies and proteins were used to assess for the significance of particular monocyte-platelet interactions in the mechanism; (3) additional experiments and mathematical modeling was performed to extrapolate our new mechanistic knowledge to enhance extracorporeal photochemotherapy (ECP), an immunotherapy in clinical use. Results showed direct correlation between platelet exposure and level of DC differentiation
Plaque parapsoriasis. Clinical view of lesions on the back of a 42-year-old man in a case of plaque parapsoriasis. Parapsoriasis refers to skin disorders that resemble the scaly lesions that form in psoriasis, though the cause is different. Forms of parapsoriasis include large plaque parapsoriasis and small plaque parapsoriasis. - Stock Image C034/8059
My journey started when I was six years old. When I was six I had noticed some white patches on my skin. I then went to a dermatologist, who had found it was vitiligo, an autoimmune disease. I had been through several skin creams, and by the time I was ten I started puva! I started puva and had success. After using that for a while I had noticed some unexplained bruising. The dermatologist recommended that I stop using puva, and that I see a hematologist.. I then went to a hematologist who ran a series of tests. She gave us an idea of what it could be, she said it might be the early stages of lupus. The labs all came back fine. She said whatever it is, it now isnt showing in the lab work and it might come further down the road. By this time I was about 12, I started having some mild joint pains. My family and I had just assumed it was from competitive gymnastics that I had been doing for the last six years. So I just dealt with it.. As years went by, I had later became pregnant. In December of ...
The safety of psoralen photochemotherapy (PUVA) in relation to the eye has been an area of research at the Washington Hospital Center for the last 6 years. Our studies indicate that, with proper shielding of the eye, safety for acute lenticular damag
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies. ...
THOUSAND OAKS, Calif. and COLLEGEVILLE, Pa., Feb. 7 -- A global Phase 3 study of Enbrel(R) (etanercept) demonstrated that a significant number of psoriasis patients given initial loading doses of ENBREL for three months rapidly achieved psoriasis clearing and then maintained the response while receiving half the drug dose. These data were presented at the American Academy of Dermatology annual meeting in Washington, D.C.. In this double-blind, placebo-controlled study, 583 patients with moderate to severe psoriasis were randomized to receive placebo (n=193), 25 mg of ENBREL twice weekly (n=196), or a loading dose of 50 mg of ENBREL twice weekly (n=194), for 12 weeks. Following this initial period, patients then continued treatment for an additional 12 weeks. During the second 12 weeks, those taking the loading dose of ENBREL were "stepped down" to half the dose (25 mg twice weekly), while patients taking 25 mg twice weekly continued with the same dose. Patients initially taking placebo were ...
The report offers a comprehensive evaluation of the market. Increasing applications of photopheresis products market in the medical world are bolstering the market in developed regions. photopheresis products market represents the fastest growing market since the past few years.
Ansteckend ist die Psoriasis definitiv nicht, kann jedoch vererbt werden. Hufigkeit und Schwere der Schbe; Dauer der (relativ) beschwerdefreien Zeitrume. Schwerer therapieresistenter behindernder Psoriasis vulgaris, die nicht ausreichend auf andere Therapieformen wie Phototherapie, PUVA und Retinoide anspricht, sowie schwerer Psoriasis arthropathica bei erwachsenen Patienten. Seltene Nebenwirkungen (kann bis zu 1 von 1.000 Behandelten betreffen):. ...
A new research from the University of Pennsylvania School of Medicine has revealed an increased incidence of major adverse cardiac events (MACE) in patients with severe psoriasis.
See Important Safety Information and Prescribing Information, including the BOXED WARNING, for UVADEX®. Hear how Anita is poised and ready to treat her CTCL skin symptoms with THERAKOS® Photopheresis.
The aim of this course is to graduate student with sound knowledge in dermatology and sexually transmitted infections through lectures,tutorials,seminars and clinical rounds. This course covered the basics that student should know (anatomy,histology,physiology of the skin and urogenital tract),functions of the skin and the primary skin lesions.Areas that student should know (common viral, fungal, bacterial infections and parasitic infestations), squamous scaly skin eruptions, diseases of skin appendages, leprosy, genitalulcers, urethral discharge,HIV AIDS are highly emphasized Knowledge about topical and systemic treatment is essential. And knowledge about photo therapy (PUVA,UVB,LASER) is important for student to hear about. Skills (clerking,eliciting demonstrating primary and secondary skin lesions) performing cautery curettage and doing skin biopsy are conducted in this course. Attitude towardspatients, juniorstaff, colleagues and senior staff can be gained.. ...
Primär kutane Lymphome sind typische Krankheitsbilder in der Dermatologie. Obwohl diese Erkrankungen zu den seltenen Krankheiten zählen, sind sie jedoch von therapeutischem und wissenschaftlichen Interesse. Der erste Teil der Arbeit beschäftigt sich mit der Klassifikation und Therapie primär kutaner Lymphome. Die 1997 veröffentlichte EORTC-Klassifikation wird mit ihren wichtigsten Entitäten erläutert. Die EORTC-Klassifikation geht auf spezifische Besonderheiten der primär kutanen Lymphome ein und orientiert sich an der guten Prognose dieser Erkrankungen. Therapeutische Strategien wie der Einsatz von für kutane Lymphome typische Behandlungsmethoden (PUVA, Exzision, Radiatio) als auch gentechnisch hergestellte Medikamente wie therapeutische Antikörper und Vakzinen werden erklärt. Der zweiten Teil der Habilitationsschrift konzentriert sich auf experimentelle Arbeiten zur molekularbiologischen Untersuchung von primär kutanen Lymphomen. Im Mittelpunkt steht die Methode der ...
Learn about Panretin (Alitretinoin) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.
Die Universität zu Köln ist eine Exzellenzuniversität mit dem klassischen Fächerspektrum einer Volluniversität. Als eine der größen Hochschulen Europas arbeitet sie in Forschung und Lehre auch international auf höchstem Niveau.
Results Twenty three patients (13 W/10 M;mean age of 37±12 years) with a mean evolution of psoriasis of 19,9±13.1 years were included. Six patients also had (26%) arthritis. Comparison of clinical and histological parameters at baseline and 6 months of treatment with ADA shown in TABLE. At the baseline visit the following values were significantly higher in skin biopsy with psoriasis than in healthy skin: a) levels of angiogenesis (endothelial area positive-CD31): 2274,2±833,1 vs 810,61±425,2 (p,0.001); b) positive expression of VEGF: 87% vs 8,7% (p,0.001) y c) positive expression of TNFα: 82,6 vs 4,3% (p,0.001). A significant clinical and histological improvement in the expression of TNF, VEGF and angiogenesis was observed after treatment with ADA. The clinical parameters of psoriasis and angiogenesis (VEGF, TNF and CD31) only showed a significant correlation between the improvement in PASI and basal CD31. Thus, patients with lower baseline PASI had a greater response to therapy (r=0,590; ...
People with the skin disease psoriasis are at increased risk for type 2 diabetes, and the more severe the psoriasis, the greater their risk, a new study finds.
Using antidepressants for psoriasis may help as the autoimmune skin condition appears to involve serotonin, but should dermatologists prescribe them?
Patients with psoriasis are more likely to have a wide range of other conditions, from metabolic disorders to peptic ulcers, a study has shown
The Department of Health recommends that, when looking for a hypnotherapist, you consult with someone who is CNHC registered. ...
I have had moderate to severe psoriasis since I was seven. I have been on numerous medications and have plenty of experience dealing with psoriasis. If you have
According to WebMD, psoriasis does not generally lead to death. However, one study noted that men with severe psoriasis tended to die 3.5 years before those without the condition, and women with...
A new drug called ixekizumab has been found to completely clear the plaques in 40% psoriasis patients, while 90% experienced some improvement in symptoms.
Treatment options of Vitiligo:. 1. Steroid Intake:. Most skin experts recommend increasing the intake of Vitamin D and steroids to recover Vitiligo correctly. The steroid supports in re-pigment discolored parts, and the Vitamin D supports replace dead skin cells.. 2. Topical Corticosteroid Creams:. Vitiligo patients can use these skin creams on your their skin to initiate re-pigmentation cells of the skin.. 3. Oral PUVA Therapy:. Oral PUVA therapies can assistance to recover severe Vitiligo issues in People.. Natural Treatment Choices for Vitiligo:. Psoralea seeds, Radish Seeds, Basil leaves and lime juice, Red clay, Copper treated water, Turmeric, Babchi seeds are some Herbal options for Vitiligo Natural Treatment. These herbal seeds work in vitiligo treatment naturally without any side effects.. ...
plaque psoriasis diagnosis,plaque psoriasis drugs,plaque psoriasis elbow,plaque psoriasis injection,plaque psoriasis lotion,plaque psoriasis medications,plaque psoriasis meds,plaque psoriasis natural treatment,plaque psoriasis photos,plaque psoriasis pictures,plaque psoriasis pill,plaque psoriasis prescription,plaque psoriasis prescription drugs,plaque psoriasis relief,plaque psoriasis scalp,plaque psoriasis symptoms,plaque psoriasis therapy,plaque psoriasis topical treatment,plaque psoriasis treatment,plaque psoriasis treatment brands,plaque psoriasis treatment drugs,plaque psoriasis treatment options,plaxpsoriasis,prescription cream for psoriasis,prescription drugs…
Adalimumab (Humira) is a recombinant human monoclonal antibody against tumor necrosis factor alpha (TNF- α), which works by blocking the interaction of TNF- α with its cell-surface receptors, thereby limiting the progression of inflammatory pathways. Its use is approved for several autoimmune conditions including chronic plaque psoriasis for which it has been prescribed as a first-line biologic treatment. Increased risks of malignancy, particularly non-melanoma skin cancer and non-CNS lymphomas have been reported with use of this drug, however, there have been no reports of CNS lymphomas.. Here, we report the case of a 43-year old male who presented for evaluation following recent speech difficulty and a generalized tonic-clonic seizure. He has a medical history significant for plaque psoriasis on treatment with adalimumab for 4 months. An MRI brain with contrast showed a well defined rounded enhancing lesion in the left temporal lobe with circumferential vasogenic edema. There was mass effect ...
SKOKIE, Ill., April 26, 2016 (GLOBE NEWSWIRE) -- Exicure, a pioneer in developing Spherical Nucleic Acid (SNA™) constructs as gene regulatory and immunotherapeutic agents, today announced the dosing of the first patient in a Phase 1 trial of its AST-005 gel for chronic plaque psoriasis, an inflammatory disease that results in red, scaly patches on the skin.. Current treatments for psoriasis are limited to biologics, which are generally administered systemically, orally administered drugs and a variety of non-drug solutions, including phototherapy, and non-targeted topical treatments. With AST-005, Exicure is taking advantage of the unique ability of SNA constructs to penetrate the skin when applied topically. As a consequence, AST-005 combines the targeted benefits of biologics with the ease of application of topical steroids.. AST-005 is a topically-applied SNA that targets tumor necrosis factor (TNF), a pro-inflammatory cytokine shown to be a key mediator of psoriasis. In preclinical ...
Albany, NY -- 01/12/2018 -- Psoriasis is an autoimmune disease which is characterized by scaly patches of skin with inflammation and causes excessive production of new skin cells. Presently, there are no long term therapeutics available for the treatment of psoriasis. Chronic Plaque psoriasis is the one of the most common type of psoriasis. This…
Adults aged 18 years or older with a diagnosis of chronic plaque psoriasis may qualify to participate. Individuals must have moderate to severe disease according to physicians clinical judgment. Both
Patients characteristics are presented in Table 1 (online appendix). They showed a median age of 67 yrs., a prevalence of male sex (14 men and 5 women) and II B-IV stage. Most (68%) had MF at various stage, including the folliculotropic variant (23%) and MF transformed into large-cell lymphoma (23%). Sixteen percent of patients had SS and 16% peripheral T-cell lymphoma-unspecified (PTCL-U). All patients had received other therapies before Peg-Doxo. These ranged from topical or oral steroids, PUVA therapy, systemic retinoids, immunotherapy with interferon-α (IFN-α), radiotherapy and various systemic chemotherapy regimens (gemcitabine, daunoxome, chlorambucil, ATRA, fludarabine, mitoxantrone, 2CdA, VNCOP, CHOP, DHAP). One patient also received immunomagnetic purged autologous bone marrow transplantation. MF patients staging was IB in 2/13 patients, IIA in 2/13, IIB in 5/13, IIIA in 1/13, and IVB in 3/13. PTCL-U patients staging was Ann Arbor IV. The majority of patients had multiple, ...
The different forms of light therapy for psoriasis include sunlight, UVB, and PUVA therapy. As this eMedTV page explains, light therapy helps improve the appearance of scaly, inflamed skin. This page covers the benefits and risks of light therapy.
Oral retinoid use reduces cutaneous squamous cell carcinoma risk in psoriasis patients treated with PUVA: a nested cohort study ...
The invention discloses methods and compositions for enhanced skin concentration of iontophoretic delivered active agents. The compositions are pharmaceutically acceptable compositions for iontophoretic delivery which comprise a skin concentration enhancing amount of a vasoconstrictor and active agent. Methods comprise adding a skin concentration enhancing amount of a vasoconstrictor to an active agent and delivering by iontophoresis.
Jan 5, 2010: Edward Chu, M.D. - Chinese Herbal Medicine in the Treatment of G.I. Cancer: From Bench to Bedside. Jan 5, 2010: Joanne B. Weidhaas, M.D., Ph.D. - The KRAS-variant and Cancer Risk. Feb 2, 2010: Nina S. Kadan-Lottick, M.D., M.S.P.H. - The Yale HEROS Clinic: A Clinical and Research Program for Childhood Cancer Survivors. Feb 2, 2010: Richard L. Edelson, M.D. - Personalized Dendritic Cell Immunotherapy: Deciphering the Scientific Mechanism of Extracorporeal Photochemotherapy. Feb 9, 2010: Gil G. Mor, M.D., Ph.D. - Role of Ovarian Cancer Stem Cells in Recurrence and Metastasis. Feb 9, 2010: Lyndsay N. Harris, M.D. - Breast Cancer Genomics: Therapeutic Applications. Feb 16, 2010: Peter M. Glazer, M.D., Ph.D. - Hypoxia, DNA Repair and Cancer Therapy. Feb 16, 2010: Bryan W. Chang, M.D. - Stereotactic Body Radiation Therapy (SBRT) for Liver Tumors. Feb 23, 2010: Madhav Dhodapkar - Stemness, Inflammation and Tumor Immunity: From Bedside to the Bench and Back. Feb 23, 2010: David G. Schatz, ...